HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Geraci, S. A. Articles by Haan, C. K. Search for Related Content PubMed PubMed Citation Articles by Geraci, S. A. Articles by Haan, C. K. Related Collections Electrophysiology - arrhythmias

Ann Thorac Surg 2002;74:1727-1732
© 2002 The Society of Thoracic Surgeons

---

Review

Effect of beta blockers after coronary artery bypass in postinfarct patients: what can we learn from available literature?

^a Section of Cardiovascular Medicine, Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin,, USA
^b Division of Cardiothoracic Surgery, Department of Surgery, University of Florida Health Science Center, Jacksonville, Florida, USA

* Address reprint requests to Dr Haan, Division of Cardiothoracic Surgery, University of Florida Health Science Center, 655 W. 8th St, Jacksonville, FL, 32209, USA.
e-mail: connie.haan{at}jax.ufl.edu

Studies have shown that beta adrenergic antagonist therapy benefits patients with coronary disease through reduced mortality rate after acute myocardial infarction and reduced incidence of postoperative atrial fibrillation after coronary artery bypass grafting. The long-term benefit of this therapy in survivors of myocardial infarction who are subsequently revascularized, however, has not been defined or studied rigorously. We reviewed the published data to clarify the role of beta blockade in patients who had surgical revascularization after myocardial infarction. We found that patients who received beta blockers after myocardial infarction had a reduced mortality rate and fewer cardiac events in most clinical situations, a benefit which likely extends to patients who have had subsequent surgical revascularization.

This article has been cited by other articles:

				P. Wang, C. Zaragoza, and W. Holman Sodium-Hydrogen Exchange Inhibition and {beta}-Blockade Additively Decrease Infarct Size Ann. Thorac. Surg., March 1, 2007; 83(3): 1121 - 1127. [Abstract] [Full Text] [PDF]

				D. L. Ngaage, H. V. Schaff, C. J. Mullany, T. M. Sundt III, J. A. Dearani, S. Barnes, R. C. Daly, and T. A. Orszulak Does preoperative atrial fibrillation influence early and late outcomes of coronary artery bypass grafting? J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 182 - 189. [Abstract] [Full Text] [PDF]